FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

A S T Planting

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Jessica M van der Bol; Theo J Visser; Walter J Loos; Floris A de Jong; Erik A C Wiemer; Maarten O van Aken; A S T Planting; Jan H Schellens; Jaap Verweij; Ron H J Mathijssen
Effects of methimazole on the elimination of irinotecan.
Jessica M van der Bol; Ron H J Mathijssen; Geert-Jan M Creemers; A S T Planting; Walter J Loos; Erik A C Wiemer; Lena E Friberg; Jaap Verweij; Alex Sparreboom; Floris A de Jong
A CYP3A4 phenotype-based dosing algorithm for individualized treatment of irinotecan.
S Bipat; M S van Leeuwen; W J G Oyen; A S T Planting; Jan N M Ijzermans; J Stoker
[Imaging in the diagnosis of colorectal liver metastases and extrahepatic abnormalities].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of A S T Planting (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Jessica M van der Bol; Theo J Visser; Walter J Loos; Floris A de Jong; Erik A C Wiemer; Maarten O van Aken; A S T Planting; Jan H Schellens; Jaap Verweij; Ron H J Mathijssen
Effects of methimazole on the elimination of irinotecan.
Cancer chemotherapy and pharmacology 2011;67(1):231-6.
2010: Jessica M van der Bol; Ron H J Mathijssen; Geert-Jan M Creemers; A S T Planting; Walter J Loos; Erik A C Wiemer; Lena E Friberg; Jaap Verweij; Alex Sparreboom; Floris A de Jong
A CYP3A4 phenotype-based dosing algorithm for individualized treatment of irinotecan.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(2):736-42.
2008: S Bipat; M S van Leeuwen; W J G Oyen; A S T Planting; Jan N M Ijzermans; J Stoker
[Imaging in the diagnosis of colorectal liver metastases and extrahepatic abnormalities].
Nederlands tijdschrift voor geneeskunde 2008;152(15):857-62.
2008: A F J de Bruin; Joost J Nuyttens; Floris T J Ferenschild; A S T Planting; Cornelis Verhoef; Johannes H W de Wilt
Preoperative chemoradiation with capecitabine in locally advanced rectal cancer.
The Netherlands journal of medicine 2008;66(2):71-6.
2008: Ferry A L M Eskens; Constantijne H Mom; A S T Planting; Jourik A Gietema; A Amelsberg; H Huisman; L van Doorn; Herman Burger; P Stopfer; Jaap Verweij; E G E de Vries
A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours.
British journal of cancer 2008;98(1):80-5.
2007: Jessica van der Bol; Ron H J Mathijssen; Walter J Loos; Lena E Friberg; Ron van Schaik; M J A de Jonge; A S T Planting; Jaap Verweij; Alex Sparreboom; Floris A de Jong
Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2719-26.
2007: Henk van Halteren; A H Liem; A S T Planting
[Myocardial ischaemia as a result of treatment with capecitabine].
Nederlands tijdschrift voor geneeskunde 2007;151(26):1469-73.
2007: Cornelis Verhoef; J J Nuytens; A S T Planting; Johannes H W de Wilt
Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (Br J Surg 2006; 93; 872-878).
The British journal of surgery 2007;94(2):250.
2007: Shandra Bipat; Maarten S van Leeuwen; Jan N M Ijzermans; Emile F I Comans; A S T Planting; Patrick Bossuyt; J-W Greve; Jaap Stoker
Evidence-base guideline on management of colorectal liver metastases in the Netherlands.
The Netherlands journal of medicine 2007;65(1):5-14.
2006: Floris A de Jong; Diederik F S Kehrer; Ron H J Mathijssen; Geert-Jan Creemers; Peter de Bruijn; Ron van Schaik; A S T Planting; Ate van der Gaast; Ferry A L M Eskens; Jos Th P Janssen; Jan B Ruit; Jaap Verweij; Alex Sparreboom; M J A de Jonge
Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled study.
The oncologist 2006;11(8):944-54.
2005: Ronald Hoekstra; Herlinde Dumez; Ferry A L M Eskens; Ate van der Gaast; A S T Planting; Gerda de Heus; Kurt C Sizer; Christina Ravera; Sujata Vaidyanathan; Corazon D Bucana; Isaiah J Fidler; Allan T van Oosterom; Jaap Verweij
Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 1):6908-15.
2005: M J A de Jonge; Ate van der Gaast; A S T Planting; Leny van Doorn; Aletta Lems; Inge Boot; Jantien Wanders; Masahiko Satomi; Jaap Verweij
Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(10):3806-13.
2005: Stefan Sleijfer; Ate van der Gaast; A S T Planting; Gerrit Stoter; Jaap Verweij
The potential of statins as part of anti-cancer treatment.
European journal of cancer (Oxford, England : 1990) 2005;41(4):516-22.
2005: A S T Planting; Ate van der Gaast; Patrick Schöffski; Michele Bartkowski; Coleta Verheij; Dennis Noe; Karen Ferrante; Jaap Verweij
A phase I and pharmacologic study of the matrix metalloproteinase inhibitor CP-471,358 in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2005;55(2):136-42.
2005: A S T Planting; M de Jong; Peter Jansen; Jeroen D F Kerrebijn; M Smith; Jaap Verweij
Phase I study of concomitant chemoradiation with raltitrexed in locally advanced head and neck cancer.
European journal of cancer (Oxford, England : 1990) 2005;41(1):93-7.
2005: A S T Planting; Pieter Sonneveld; Ate van der Gaast; Alex Sparreboom; M E L van der Burg; G P M Luyten; K de Leeuw; MM de Boer-Dennert; Paul Wissel; Roxanne C Jewell; Elaine M Paul; N B Purvis; Jaap Verweij
A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2005;55(1):91-9.
2004: Alex Sparreboom; Diederik F S Kehrer; Ron H J Mathijssen; R Xie; M J A de Jonge; Peter de Bruijn; A S T Planting; Ferry A L M Eskens; Coleta Verheij; Gerda de Heus; A Klaren; S Zhang; Tom Verhaeghe; Peter A Palmer; Jaap Verweij
Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor.
British journal of cancer 2004;90(8):1508-15.
2004: Lia van Zuylen; John Bridgewater; Alex Sparreboom; Ferry A L M Eskens; Peter de Bruijn; Ivo Sklenar; A S T Planting; Les Choi; Douglas Bootle; Christian Mueller; Jonathan A Ledermann; Jaap Verweij
Phase I and pharmacokinetic study of the polyamine synthesis inhibitor SAM486A in combination with 5-fluorouracil/leucovorin in metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):1949-55.
2004: Otto Soepenberg; Alex Sparreboom; M J A de Jonge; A S T Planting; Gerda de Heus; Walter J Loos; C M Hartman; C Bowden; Jaap Verweij
Real-time pharmacokinetics guiding clinical decisions; phase I study of a weekly schedule of liposome encapsulated paclitaxel in patients with solid tumours.
European journal of cancer (Oxford, England : 1990) 2004;40(5):681-8.
2003: Albert J ten Tije; Jaap Verweij; Alex Sparreboom; Ate van der Gaast; Camilla Fowst; francesco Fiorentini; Jennifer Tursi; Alessandro Antonellini; Marijke Mantel; Carla M Hartman; Gerrit Stoter; A S T Planting; M J A de Jonge
Phase I and pharmacokinetic study of brostallicin (PNU-166196), a new DNA minor-groove binder, administered intravenously every 3 weeks to adult patients with metastatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(8):2957-64.
2003: Felix E de Jongh; Ruben N van Veen; S J Veltman; Ronald de Wit; M E L van der Burg; Martin J van den Bent; A S T Planting; Wilfried J Graveland; Gerrit Stoter; Jaap Verweij
Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients.
British journal of cancer 2003;88(8):1199-206.
2003: J H M Schellens; A S T Planting; nico van zandwijk; J Ma; Marc Maliepaard; M E L van der Burg; MM de Boer-Dennert; E Brouwer; Ate van der Gaast; Martin J van den Bent; Jaap Verweij
Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer.
British journal of cancer 2003;88(6):814-21.
2003: C M F Kruijtzer; Henk Boot; Jos H Beijnen; H L Lochs; F X Parnis; A S T Planting; J M G Pelgrims; R Williams; Ron A A Mathôt; Hilde Rosing; Margaret Schot; Harm van Tinteren; J H M Schellens
Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):197-204.
2002: M J A de Jonge; Jaap Verweij; Ate van der Gaast; Olga Valota; O Mora; A S T Planting; Marijke Mantel; S Van Den Bosch; M J Lechuga; francesco Fiorentini; D Hess; Cristiana Sessa
Phase I and pharmacokinetic studies of PNU-159548, a novel alkycycline, administered intravenously to patients with advanced solid tumours.
European journal of cancer (Oxford, England : 1990) 2002;38(18):2407-15.
2002: Herlinde Dumez; M Louwerens; A Pawinsky; A S T Planting; M J A de Jonge; Allan T van Oosterom; Martin Highley; Gunther Guetens; Marijke Mantel; Gert de Boeck; Ernst A de Bruijn; Jaap Verweij
The impact of drug administration sequence and pharmacokinetic interaction in a phase I study of the combination of docetaxel and gemcitabine in patients with advanced solid tumors.
Anti-cancer drugs 2002;13(6):583-93.
2002: M J A de Jonge; Cornelis J A Punt; Alex Sparreboom; A S T Planting; M E W J Peters; Jacqueline van De Schraaf; Ann Jackman; Rob Smith; P H M De Mulder; Jaap Verweij
Phase I and pharmacologic study of oral ZD9331, a novel nonpolyglutamated thymidylate synthase inhibitor, in adult patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1923-31.
2002: D J Th Wagener; Jacques A Wils; T C Kok; A S T Planting; ML Couvreur; Benoît Baron
Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with alpha-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial.
European journal of cancer (Oxford, England : 1990) 2002;38(5):648-53.
2001: J H M Schellens; A S T Planting; J Ma; Marc Maliepaard; A de Vos; MM de Boer-Dennert; Jaap Verweij
Adaptive intrapatient dose escalation of cisplatin in patients with advanced head and neck cancer.
Anti-cancer drugs 2001;12(8):667-75.
2001: Felix E de Jongh; Jaap Verweij; Walter J Loos; Ronald de Wit; M J A de Jonge; A S T Planting; Kees Nooter; Gerrit Stoter; Alex Sparreboom
Body-surface area-based dosing does not increase accuracy of predicting cisplatin exposure.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(17):3733-9.
2000: Carolien H Smorenburg; Caroline Seynaeve; Marijke Bontenbal; A S T Planting; H Sindermann; Jaap Verweij
Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients.
Anti-cancer drugs 2000;11(10):825-8.
2000: A J Gelderblom; Walter J Loos; M J A de Jonge; Alex Sparreboom; A S T Planting; M E L van der Burg; E Brouwer; Coleta Verheij; L Ouwens; Solange Hearn; Jaap Verweij
Phase I and pharmacological study of increased dose oral topotecan in combination with intravenous cisplatin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(9):1205-7.
2000: LC Pronk; P Vasey; Alex Sparreboom; Bruno Reigner; A S T Planting; RJ Gordon; B Osterwalder; Jaap Verweij; Chris Twelves
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours.
British journal of cancer 2000;83(1):22-9.
2000: Ferry A L M Eskens; GA Greim; C van Zuylen; I Wolff; LJ Denis; A S T Planting; F A Muskiet; Jantien Wanders; Nicholas C Barbet; Les Choi; Renaud Capdeville; Jaap Verweij; Axel R Hanauske; U Bruntsch
Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies Group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1736-43.
2000: M J A de Jonge; Walter J Loos; Hans Gelderblom; A S T Planting; M E L van der Burg; Alex Sparreboom; E Brouwer; V van Beurden; Marijke Mantel; E Doyle; Solange Hearn; G Ross; Jaap Verweij
Phase I pharmacologic study of oral topotecan and intravenous cisplatin: sequence-dependent hematologic side effects.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(10):2104-15.
2000: M J A de Jonge; Alex Sparreboom; A S T Planting; M E L van der Burg; MM de Boer-Dennert; Judith ter Steeg; Christian Jacques; Jaap Verweij
Phase I study of 3-week schedule of irinotecan combined with cisplatin in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(1):187-94.
1999: A S T Planting; J H M Schellens; M E L van der Burg; MM de Boer-Dennert; B Winograd; Gerrit Stoter; Jaap Verweij
Phase I and pharmacologic study of BMS-181174 given as a 6 h infusion every 4 weeks to patients with advanced solid tumors.
Anti-cancer drugs 1999;10(9):821-7.
1999: Alex Sparreboom; A S T Planting; Roxanne C Jewell; M E L van der Burg; Ate van der Gaast; Peter de Bruijn; Walter J Loos; Kees Nooter; L H Chandler; Elaine M Paul; Paul Wissel; Jaap Verweij
Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoprotein.
Anti-cancer drugs 1999;10(8):719-28.
1999: M J A de Jonge; Jaap Verweij; A S T Planting; M E L van der Burg; Gerrit Stoter; MM de Boer-Dennert; Peter de Bruijn; E Brouwer; Laurent Vernillet; Alex Sparreboom
Drug-administration sequence does not change pharmacodynamics and kinetics of irinotecan and cisplatin.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):2012-7.
1999: M J A de Jonge; Cornelis J A Punt; A H Gelderblom; Walter J Loos; V van Beurden; A S T Planting; M E L van der Burg; Lydia Van Maanen; BK Dallaire; Jaap Verweij; D J Wagener; Alex Sparreboom
Phase I and pharmacologic study of oral (PEG-1000) 9-aminocamptothecin in adult patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2219-26.
1999: A S T Planting; G Catimel; P H de Mulder; A de Graeff; F Höppener; Jaap Verweij; Wolfgang Oster; J B Vermorken
Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(6):693-700.
1999: Peter de Bruijn; Jaap Verweij; Walter J Loos; HJ Kolker; A S T Planting; Kees Nooter; Gerrit Stoter; Alex Sparreboom
Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography.
Analytical biochemistry 1999;266(2):216-21.
1999: Patrick Schöffski; G Catimel; A S T Planting; J P Droz; Jaap Verweij; Dirk Schrijvers; L Gras; A Schrijvers; Jantien Wanders; Axel R Hanauske
Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(1):119-22.
1999: C J H Gerrits; J H M Schellens; Howard A Burris; John R Eckardt; A S T Planting; M E L van der Burg; Gladys I Rodriguez; Walter J Loos; V van Beurden; IR Hudson; Daniel Von Hoff; Jaap Verweij
A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin)
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(1):69-75.
1998: M Mackean; A S T Planting; Chris Twelves; J Schellens; D Allman; B Osterwalder; Bruno Reigner; T Griffin; S Kaye; Jaap Verweij
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):2977-85.
1998: C J H Gerrits; Howard A Burris; J H M Schellens; A S T Planting; M E van den Burg; Gladys I Rodriguez; V van Beurden; Walter J Loos; IR Hudson; S Fields; Jaap Verweij; Daniel Von Hoff
Five days of oral topotecan (Hycamtin), a phase I and pharmacological study in adult patients with solid tumours.
European journal of cancer (Oxford, England : 1990) 1998;34(7):1030-5.
1998: Ronald de Wit; Wim H J Kruit; C H Lamers; Mars B van 't Veer; A A Luyten; V van Beurden; M Harteveld; A S T Planting; P I M Schmitz; Gerrit Stoter; Reinder L H Bolhuis; Jaap Verweij
A phase I/II study of multicyclic dose-intensive chemotherapy supported with G-CSF, or G-CSF and haematopoietic progenitor cells in whole blood, in two consecutive cohorts of patients.
British journal of cancer 1998;77(12):2363-6.
1998: C J H Gerrits; Howard A Burris; J H M Schellens; John R Eckardt; A S T Planting; M E L van der Burg; Gladys I Rodriguez; Walter J Loos; V van Beurden; IR Hudson; S Fields; Daniel Von Hoff; Jaap Verweij
Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(5):1153-8.
1998: LC Pronk; Dirk Schrijvers; J H M Schellens; Ernst A de Bruijn; A S T Planting; D Locci-Tonelli; V Groult; Jaap Verweij; AT van Oosterom
Docetaxel and ifosfamide in patients with advanced solid tumors: results of a phase I study.
Seminars in oncology 1998;25(1 Suppl 2):23-8.
1998: LC Pronk; Dirk Schrijvers; J H M Schellens; Ernst A de Bruijn; A S T Planting; D Locci-Tonelli; V Groult; Jaap Verweij; AT van Oosterom
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours.
British journal of cancer 1998;77(1):153-8.
1997: TM Sahmoud; Pieter E Postmus; C van Pottelsberghe; Karin Mattson; Lauri Tammilehto; Ted A W Splinter; A S T Planting; Tom G Sutedja; J van Pawel; nico van zandwijk; Paul Baas; K J Roozendaal; M Schrijver; A Kirkpatrick; M Van Glabbeke; Andrea Ardizzoni; Giuseppe Giaccone
Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group.
European journal of cancer (Oxford, England : 1990) 1997;33(13):2211-5.
1997: Geert-Jan Creemers; C J H Gerrits; John R Eckardt; J H M Schellens; Howard A Burris; A S T Planting; Gladys I Rodriguez; Walter J Loos; IR Hudson; C Broom; Jaap Verweij; Daniel Von Hoff
Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1087-93.
1997: LC Pronk; J H M Schellens; A S T Planting; Martin J van den Bent; P H E Hilkens; M E L van der Burg; MM de Boer-Dennert; J Ma; C Blanc; M Harteveld; R Bruno; Gerrit Stoter; Jaap Verweij
Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1071-9.
1997: C J H Gerrits; J H M Schellens; Geert-Jan Creemers; Paul Wissel; A S T Planting; J F Pritchard; S DePee; MM de Boer-Dennert; M Harteveld; Jaap Verweij
The bioavailability of oral GI147211 (GG211), a new topoisomerase I inhibitor.
British journal of cancer 1997;76(7):946-51.
1997: A S T Planting; S Kho; M E L van der Burg; H Goey; J H M Schellens; Martin J van den Bent; Ate van der Gaast; MM de Boer-Dennert; Gerrit Stoter; Jaap Verweij
A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 1997;40(4):347-52.
1997: A S T Planting; P H M De Mulder; A de Graeff; Jaap Verweij
Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck.
European journal of cancer (Oxford, England : 1990) 1997;33(1):61-5.
1996: A S T Planting; Ronald de Wit; M E L van der Burg; Gerrit Stoter; Jaap Verweij
Phase II study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(10):1080-2.
1996: A S T Planting; M E L van der Burg; Swan Hoo Goey; J H M Schellens; C Vecht; MM de Boer-Dennert; Gerrit Stoter; Jaap Verweij
Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic malignant melanoma.
European journal of cancer (Oxford, England : 1990) 1996;32A(11):2026-8.
1996: Geert-Jan Creemers; C J H Gerrits; J H M Schellens; A S T Planting; M E L van der Burg; V van Beurden; MM de Boer-Dennert; M Harteveld; Walter J Loos; IR Hudson; Gerrit Stoter; Jaap Verweij
Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2540-5.
1996: J H M Schellens; J Ma; A S T Planting; M E L van der Burg; E van Meerten; MM de Boer-Dennert; P I M Schmitz; Gerrit Stoter; Jaap Verweij
Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours.
British journal of cancer 1996;73(12):1569-75.
1996: A S T Planting; M E L van der Burg; Martin J van den Bent; MM de Boer-Dennert; Gerrit Stoter; J Verweij
Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic colorectal cancer.
British journal of cancer 1996;73(10):1265-7.
1996: C J H Gerrits; Geert-Jan Creemers; J H M Schellens; Paul Wissel; A S T Planting; R Kunka; K Selinger; MM de Boer-Dennert; Y Marijnen; M Harteveld; Jaap Verweij
Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administration.
British journal of cancer 1996;73(6):744-50.
1996: A S T Planting; P Helle; P Drings; Otilia Dalesio; A Kirkpatrick; G McVie; Giuseppe Giaccone
A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer. An EORTC Lung Cancer Cooperative Group trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(2):139-44.
1996: Ronald de Wit; P I M Schmitz; Jaap Verweij; MM de Boer-Dennert; P H M De Mulder; A S T Planting; M E L van der Burg; Gerrit Stoter
Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):644-51.
1996: Ate van der Gaast; J Verwij; A S T Planting; Gerrit Stoter; SC Henzen-Logmans
The value of immunohistochemistry in patients with poorly differentiated adenocarcinomas and undifferentiated carcinomas of unknown primary.
Journal of cancer research and clinical oncology 1996;122(3):181-85.
1996: J Ma; Jaap Verweij; A S T Planting; HJ Kolker; Walter J Loos; MM de Boer-Dennert; M E L van der Burg; Gerrit Stoter; J H M Schellens
Docetaxel and paclitaxel inhibit DNA-adduct formation and intracellular accumulation of cisplatin in human leukocytes.
Cancer chemotherapy and pharmacology 1996;37(4):382-4.
1995: A S T Planting; M E L van der Burg; Swan Hoo Goey; J H M Schellens; Martin J van den Bent; MM de Boer-Dennert; G Stoter; J Verweij
Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in pleural mesothelioma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(6):613-5.
1995: Ate van der Gaast; Jaap Verweij; A S T Planting; W C Hop; G Stoter
Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1720-5.
1995: Marijke Bontenbal; A S T Planting; Jaap Verweij; Ronald de Wit; Wim H J Kruit; G Stoter; Jan G M Klijn
Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancer.
Breast cancer research and treatment 1995;34(2):185-9.
1995: J Ma; Jaap Verweij; A S T Planting; MM de Boer-Dennert; H E van Ingen; M E L van der Burg; G Stoter; J H M Schellens
Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repair.
British journal of cancer 1995;71(3):512-7.
1995: A S T Planting; M E L van der Burg; MM de Boer-Dennert; G Stoter; Jaap Verweij
Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(2):190-2.
1995: P H E Hilkens; M E L van der Burg; J W Moll; A S T Planting; W L van Putten; Charles J Vecht; Martin J van den Bent
Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration.
European journal of cancer (Oxford, England : 1990) 1995;31A(5):678-81.
1994: Ate van der Gaast; Marijke Bontenbal; A S T Planting; T C Kok; T A Splinter
Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):858-60.
1994: J H M Schellens; A S T Planting; B A van Acker; Walter J Loos; MM de Boer-Dennert; M E L van der Burg; I Koier; R T Krediet; G Stoter; Jaap Verweij
Phase I and pharmacologic study of the novel indoloquinone bioreductive alkylating cytotoxic drug E09.
Journal of the National Cancer Institute 1994;86(12):906-12.
1994: A S T Planting; J H M Schellens; Swan Hoo Goey; M E L van der Burg; MM de Boer-Dennert; G Stoter; Jaap Verweij
Weekly high-dose cisplatin in malignant pleural mesothelioma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(4):373-4.
1994: LC Pronk; A S T Planting; R Oosterom; T E Drogendijk; G Stoter; Jaap Verweij
Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine.
European journal of cancer (Oxford, England : 1990) 1994;30A(7):1019-22.
1993: Ate van der Gaast; SC Henzen-Logmans; A S T Planting; G Stoter; Jaap Verweij
Phase II study of oral administration of etoposide for patients with well- and moderately-differentiated adenocarcinomas of unknown primary site.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(9):789-90.
1993: A S T Planting; M E L van der Burg; MM de Boer-Dennert; G Stoter; Jaap Verweij
Phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumours.
British journal of cancer 1993;68(4):789-92.
1993: Jaap Verweij; B Lund; Jos H Beijnen; A S T Planting; MM de Boer-Dennert; I Koier; Hilde Rosing; H Hansen
Phase I and pharmacokinetics study of topotecan, a new topoisomerase I inhibitor.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(8):673-8.
1993: A S T Planting; G Stoter; Jaap Verweij
Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(4):518-9.
1992: Jaap Verweij; A S T Planting; M de Boer; M E L van der Burg; G Stoter
Frequent administration of Dabis Maleate, a phase I study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(3):241-2.
1992: Marijke Bontenbal; A S T Planting; C J Rodenburg; A Dees; Jaap Verweij; C C Bartels; J Alexieva-Figusch; Wim L J van Putten; Jan G M Klijn
Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancer.
Breast cancer research and treatment 1992;21(2):133-8.
1992: Jaap Verweij; A S T Planting; M van der Burg; G Stoter
A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic solid tumours.
Journal of cancer research and clinical oncology 1992;118(8):606-8.
1991: A S T Planting; A Hoff; M van der Burg; Jaap Verweij; G Stoter
Phase II study of ACNU as first-line treatment in advanced colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(10):767-8.
1991: Jaap Verweij; H Herweijer; R Oosterom; M E L van der Burg; A S T Planting; C Seynaeve; G Stoter; Kees Nooter
A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance.
British journal of cancer 1991;64(2):361-4.
1991: M E L van der Burg; A S T Planting; G Stoter; C McDaniel; C J Vecht; Jaap Verweij
Phase I study of DABIS maleate given once every 3 weeks.
European journal of cancer (Oxford, England : 1990) 1991;27(12):1635-7.
1990: A Dees; J L Ligthart; Wim L J van Putten; A S T Planting; G Stoter
Mechanical ventilation in cancer patients. Analysis of clinical data and outcome.
The Netherlands journal of medicine 1990;37(5-6):183-8.
1990: Jan G M Klijn; A M Hoff; A S T Planting; J Verweij; T Kok; S W Lamberts; H Portengen; John A Foekens
Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.
British journal of cancer 1990;62(4):627-30.
1990: Jaap Verweij; A S T Planting; Ate van der Gaast; G Stoter
Phase II study of cisplatin plus 24-hour infusion of ifosfamide in advanced malignant melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(1):77-8.
1989: G Anderson; M Clavel; J Smyth; Giuseppe Giaccone; M Gracia; A S T Planting; O Dalesio; A Kirkpatrick; G McVie
Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung. EORTC Lung Cancer Cooperative Group.
European journal of cancer & clinical oncology 1989;25(5):909-10.
1989: A S T Planting; M E L van der Burg; A M Hoff; Jaap Verweij; G Stoter
A phase II study of high dose ifosfamide in metastatic colorectal cancer.
European journal of cancer & clinical oncology 1989;25(1):139-40.
1988: Ate van der Gaast; Jaap Verweij; A S T Planting; G Stoter
5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary.
European journal of cancer & clinical oncology 1988;24(4):765-8.